Official Website of Louis Velazquez

Regeneron Pharma Q4 Earnings Crush Estimates, Initiates Dividend And Additional Stock Buyback Program

Regeneron beat Q4 estimates with $12.07 EPS and $3.79B in sales. The company announced a dividend, a $3 billion buyback, and continued R&D investments.

read more

Previous Post Pete Hegseth Takes Helm as Defense Secretary, Vows to Restore ‘Warrior Ethos’ Next Post This Is What Whales Are Betting On Walmart
error: (c) 2020 UCW Entertainment- Content is protected !!